Baby Gard suffers from a rare RRM2B mutation of MDDS with structured brain damage. A new therapy nucleoside therapy may benefit TK2 variants but cannot cross blood-brain barrier. The hospital requests to withdraw life support but parents could not agree. The hospital sought a declaration from the court as to the baby's best interests.
Judgment: A declaration was made that the hospital may lawfully withdraw all treatment, save for palliative care, to permit the baby to die with dignity.
P.S. Mitochondrial DNA Depletion Syndrome (MDDS): a group of autosomal recessive disorders that cause significant drop in mitochondrial DNA in affected tissues. Symptoms can be any combination of myopathic, hepatopathic, or encephalomyopathic.
Yates & Anor v GOSH for Children NHS Foundation Trust & Anor 
Appeal case to the above child - rejected by court of appeal.
Parents made application to the European Court which granted the child Interim measure until 13 June 2017 (midnight).
I'm busy working on my blog posts. Watch this space!